Antidiarrheals: Nursing pharmacology

Antidiarrheals: Nursing pharmacology

gap test med surg

gap test med surg

Aortic aneurysm: Nursing process (ADPIE)
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Left-sided heart failure: Nursing process (ADPIE)
Myocardial infarction (MI): Nursing process (ADPIE)
Pericardial effusion and cardiac tamponade: Nursing process (ADPIE)
Rheumatic heart disease: Nursing process (ADPIE)
Antihyperlipidemics - Statins: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Antihyperlipidemics - Miscellaneous: Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Medications for growth hormone disorders: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Acute kidney injury (AKI): Nursing process (ADPIE)
Benign prostatic hyperplasia (BPH): Nursing process (ADPIE)
Urinary incontinence - Stress: Nursing process (ADPIE)
Urinary tract infections (UTIs): Nursing process (ADPIE)
Hemophilia: Nursing process (ADPIE)
Leukemia: Nursing process (ADPIE)
Sickle cell disease: Nursing process (ADPIE)
Anticoagulants - Heparin: Nursing pharmacology
Antiplatelet agents: Nursing pharmacology
Hemostatics: Nursing pharmacology
Iron preparations: Nursing pharmacology
Thrombolytics: Nursing pharmacology
Antihyperlipidemics - Fibrates: Nursing pharmacology
Blood products: Nursing pharmacology
Antihyperlipidemics - Bile acid sequestrants and cholesterol absorption inhibitors: Nursing pharmacology
Anticoagulants - Direct thrombin and factor Xa inhibitors: Nursing pharmacology
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Atopic dermatitis: Nursing process (ADPIE)
Frostbite: Nursing process (ADPIE)
Methicillin-resistant Staphylococcus aureus (MRSA): Nursing process (ADPIE)
Pressure injury: Nursing process (ADPIE)
Debridement agents: Nursing pharmacology
Keratolytics: Nursing pharmacology
Antibiotics - Topical: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Corticosteroids - Topical: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Fractures: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Medications for migraines: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Antitumor antibiotics: Nursing pharmacology
Alkylating agents: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Candidiasis: Nursing process (ADPIE)
Gonorrhea and chlamydia: Nursing process (ADPIE)
Pelvic inflammatory disease (PID): Nursing process (ADPIE)
Asthma: Nursing process (ADPIE)
Bacterial pneumonia: Nursing process (ADPIE)
Carbon monoxide poisoning: Nursing process (ADPIE)
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Epiglottitis: Nursing process (ADPIE)
Foreign body aspiration and upper airway obstruction: Nursing process (ADPIE)
Laryngotracheobronchitis (LTB) and croup: Nursing process (ADPIE)
Smoke inhalation injury: Nursing process (ADPIE)
Venous thromboembolism (VTE): Nursing process (ADPIE)
Antihistamines: Nursing pharmacology
Bronchodilators: Nursing pharmacology
Corticosteroids - Inhaled: Nursing pharmacology
Mast cell stabilizers - Inhaled: Nursing pharmacology
Leukotriene modifiers: Nursing pharmacology
Medications to control airway secretions: Nursing pharmacology
Oxygen therapy: Nursing pharmacology

Notes

ANTIDIARRHEALS
DRUG NAME
loperamide (Imodium), diphenoxylate (Lomotil), difenoxin (Motofen), paregoric
octreotide (Sandostatin)
bismuth subsalicylate (Pepto-Bismol)
CLASS
Opioid and opioid-related agents
Somatostatin analogue
Adsorbent
MECHANISM OF ACTION
  • Decrease intestinal peristalsis
  • Inhibits pancreatic and gastrointestinal hormone release
  • Slows down peristalsis
  • Decreases secretion of fluid and electrolytes into the bowel lumen
  • Protective: Coats the intestinal walls
  • Antimicrobial: kills causative bacteria
  • Antisecretory: reduces fluid secretion into the bowel lumen
INDICATIONS
Diarrhea
ROUTE(S) OF ADMINISTRATION
  • PO
  • PO
  • SQ
  • IM
  • IV
  • PO
SIDE EFFECTS
  • Constipation
  • CNS and respiratory depression (if combined with other CNS depressants)
  • Loperamide: torsades de pointes and sudden death with high doses (boxed warning)
  • Constipation
  • Impaired gallbladder function and cholelithiasis

  • Constipation
CONTRAINDICATIONS AND CAUTIONS
  • Hepatic or renal impairment
  • Diarrhea caused by bacteria like Clostriodiodes, Salmonella, Shigella, or E. coli

For diphenoxylate and difenoxin:
  • Children younger than four and older adults
  • Narrow angle glaucoma
  • Diarrhea caused by bacteria like Clostriodiodes, Salmonella, Shigella, or E. coli
  • Children recovering from a viral infection
  • Clients taking aspirin
NURSING CONSIDERATIONS: ANTIDIARRHEALS
DRUG NAME
loperamide (Imodium), diphenoxylate (Lomotil), difenoxin (Motofen), paregoric
octreotide (Sandostatin)
bismuth subsalicylate (Pepto-Bismol)
ASSESSMENT AND MONITORING
  • Client history; recent travel, antibiotic use, or hospitalization; dietary history
  • Current symptoms; stool characteristics and frequency; abdominal assessment; signs of dehydration
  • Vital signs
  • Laboratory results: stool culture, CBC, electrolytes
CLIENT EDUCATION
  • Explain the purpose of medication
  • Take as directed
  • Side effects: constipation and gastrointestinal discomfort
  • Contact healthcare provider if diarrhea lasts for more than 48 hours or if signs of dehydration develop
  • May cause dizziness and drowsiness
  • Do not take with tranquilizers, sedatives, alcohol, or other opioids
  • Avoid hazardous activities
  • Take on empty stomach
  • Report right upper quadrant pain fever, chills, clay-colored stools
  • May cause black stools and/or darken tongue 
  • Do not take with other salicylates
Author: Antonia Syrnioti, MD
Author: Mara Joseph, RN
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Antidiarrheals are a group of medications that are used to treat diarrhea, which is characterized by loose, watery stool, or an increased frequency of bowel movement.

Now, based on their mechanism of action, antidiarrheals can be broadly divided into four main groups: opiates and opiate-related agents, somatostatin analogues, adsorbents, and bulk-forming agents.

Let’s start with opioids like loperamide, diphenoxylate, difenoxin, and paregoric. These are taken orally and work by stimulating the opioid receptors found in the intestinal wall, which decreases peristalsis or bowel movement.

The slowed transient time allows for increased absorption of fluid and electrolytes into the fecal mass.

Next, there are somatostatin analogues, such as octreotide. This can be administered orally, subcutaneously, intramuscularly, or intravenously, and it’s mostly used to treat diarrhea associated with certain tumors or chemotherapy.

The way octreotide works is by binding to somatostatin receptors and mimicking somatostatin’s effects.

These include inhibiting hormone release by the pancreas and gastrointestinal tract, as well as slowing down peristalsis and decreasing the secretion of fluid and electrolytes into the bowel lumen.

Moving on to adsorbents, these include bismuth subsalicylate, and are taken orally. Once in the intestinal lumen, bismuth subsalicylate has protective properties, since it can coat the walls of the intestines, as well as antimicrobial properties, since it can kill causative bacteria.

In addition, bismuth subsalicylate has antisecretory actions, so it helps reduce how much fluid is secreted into the bowel lumen.

Finally, bulk-forming agents include methylcellulose, polycarbophil, and psyllium. Now, these medications can’t be digested, so they remain in the intestinal lumen and end up getting incorporated into the stool.

As a result, bulk-forming agents work by absorbing water, making the stool swell up into a bulky mass. In addition, bulk-forming agents can be used as laxatives.

Now, the most common side effect of antidiarrheals is constipation. In addition, opioid agents can also cause central nervous system and respiratory depression if combined with other CNS depressants, like benzodiazepines, barbiturates, and alcohol.

Now, loperamide has a boxed warning regarding torsades de pointes and sudden death with high doses.

On the other hand, octreotide can impair gallbladder function, which may lead to cholelithiasis. Finally, bismuth subsalicylate may temporarily stain the tongue and stools black.

As far as contraindications go, these are mostly for the opioids. So, they should not be given to clients with severe hepatic or renal impairment, since they can induce hepatic coma.

Now, loperamide should not be used in clients younger than 2 years old or those with risk factors for QT prolongation.

On the other hand, diphenoxylate and difenoxin should be used with caution in children younger than 4 and in older adults, since these clients are at an increased risk for CNS and respiratory depression.

In addition, diphenoxylate and difenoxin are typically given in the form of preparations that contain atropine, so these should be avoided by clients with narrow angle glaucoma, since atropine can worsen the obstruction of aqueous humor drainage.

Sources

  1. "Focus on Nursing Pharmacology" LWW (2019)
  2. "Pharmacology" Elsevier Health Sciences (2014)
  3. "Mosby's 2021 Nursing Drug Reference" Mosby (2020)
  4. "Saunders Comprehensive Review for the NCLEX-RN Examination" Saunders (2016)
  5. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)